TLX · NASDAQ · Healthcare · Biotechnology

Telix Pharmaceuticals

Past month
Price unavailable
  • 52W range6.28–13.11
  • P/E ratio126.70
  • Market cap4.28B

Latest news

Loading...

About

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product ca...

telixpharma.com